Enterprise

Monday.com Reports 10% of New Revenue From AI Pricing Models

The work management platform disclosed quantifiable AI monetization alongside a $553 million share buyback as its stock trades down 74% year-over-year.

Omega Editorial· July 4, 2026· 3 min read

Monday.com has put a concrete number on its AI revenue contribution, reporting that 10% of net new annual recurring revenue in Q1 2026 came from AI-powered pricing models, according to details first reported by Yahoo Finance.

The disclosure marks a shift from product announcements to measurable monetization for the work management platform, which has seen its stock price fall 74.1% over the past year to $79.77. Management paired the AI revenue update with a $553 million share repurchase program executed during the quarter, buying back approximately 10% of outstanding shares near recent valuation lows.

Quantifying AI adoption

The 10% figure represents new AI-linked pricing models generating a measurable portion of incremental annual recurring revenue in a single quarter. For enterprise software companies navigating the transition from AI feature releases to actual revenue capture, Monday.com's disclosure provides a benchmark for how quickly new pricing can gain traction with existing customers and new accounts.

The company operates in a competitive landscape that includes Atlassian, ServiceNow, and Salesforce, all of which are embedding AI capabilities into work management and automation products. Monday.com's ability to monetize AI features through distinct pricing models, rather than bundling them into existing tiers, suggests the company has identified willingness to pay for specific AI functionality.

Why it matters

Investors have pressed software companies to demonstrate that AI investments translate into revenue, not just product roadmaps. Monday.com's Q1 data offers one of the clearer examples of AI monetization velocity in the mid-market work management category. The simultaneous deployment of capital for buybacks—while the stock trades down sharply—signals management's view that current valuation does not reflect the business trajectory, particularly as AI pricing models begin contributing to growth. For technology leaders evaluating AI monetization strategies, the 10% contribution in a single quarter provides a useful reference point for adoption timelines and pricing model effectiveness.

Capital allocation amid valuation pressure

The $553 million repurchase represents a significant capital deployment at a time when Monday.com's stock is down 44.4% year-to-date. Share buybacks executed near valuation troughs can indicate management confidence in future performance, though they also reflect a judgment that internal investment opportunities do not currently offer better returns than retiring equity at depressed prices.

The combination of AI revenue disclosure and aggressive capital return distinguishes Monday.com's approach from peers that have maintained more conservative balance sheet strategies during the recent software sector repricing. Whether the buyback timing proves advantageous will depend on the company's ability to sustain AI-driven growth and expand the revenue contribution beyond the initial 10% of net new ARR.

The Q1 2026 results were first reported by Yahoo Finance.

#monday.com#ai monetization#enterprise software#share buyback#work management#saas pricing

This is an original analysis by the Omega editorial team. Source reporting: AI Watch.

Want systems like this working for your business?

Book a Call

More in Enterprise

Enterprise· 3 min read

Heavy AI Adopters Grew Workforces 10%, New Study Finds

Companies spending over $100 per employee monthly on AI tools expanded headcount, contrasting with broader tech layoff trends.

Via AI Watch · Jul 4, 2026
Enterprise· 3 min read

Companies Shift from AI Tokenmaxxing to Strategic Model Routing

After racking up hefty bills, firms are assigning tasks to cheaper models and using routing tools to optimize costs without sacrificing performance.

Via AI Watch · Jul 4, 2026
Enterprise· 3 min read

Clinical Research AI Benchmarking Report Sets New Baseline

Survey of 400+ professionals reveals wide adoption gaps between sponsors, CROs, and sites as FDA tightens credibility standards.

Via AI Watch · Jul 4, 2026